Genomics–Metabolomics Profiling Disclosed Marine Vibrio spartinae 3.6 as a Producer of a New Branched Side Chain Prodigiosin-Reference-Cited by-同舟云学术

Genomics–Metabolomics Profiling Disclosed Marine Vibrio spartinae 3.6 as a Producer of a New Branched Side Chain Prodigiosin

Published:2020-04-10 Issue:5 Volume:83 Page:1495-1504
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Vitale Giovanni Andrea¹,Sciarretta Martina²,Palma Esposito Fortunato¹³,January Grant Garren¹,Giaccio Marianna¹,Bunk Boyke⁴,Spröer Cathrin⁴,Bajerski Felizitas⁴,Power Deborah⁵,Festa Carmen²^ORCID,Monti Maria Chiara⁶^ORCID,D’Auria Maria Valeria²,de Pascale Donatella¹³^ORCID

Affiliation:

1. Institute of Biochemistry and Cellular Biology, National Research Council (IBBC−CNR), Via Pietro Castellino 111, I-80131 Naples, Italy

2. Department of Pharmacy, University of Naples “Federico II” (UNINA), Via Domenico Montesanto, 49, I-80131 Naples, Italy

3. Stazione Zoologica Anton Dohrn (SZN), Villa Comunale di Napoli, I-80121 Naples, Italy

4. Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Inhoffenstraße 7B, 38124 Braunschweig, German

5. Centro de Ciencias do Mar (CCMAR), Universidade do Algarve Campus de Gambelas, 8005-139 Faro, Portugal

6. Department of Pharmacy, University of Salerno (UNISA), I-84084 Fisciano, SA, Italy

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

European Regional Development Fund

H2020 Marie Sklodowska-Curie Actions

Fundação para a Ciência e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.9b01159

Reference62 articles.

1. Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin

2. The biosynthesis and regulation of bacterial prodiginines

3. The Anticancer Agent Prodigiosin Is Not a Multidrug Resistance Protein Substrate

4. Biological Potential and Mechanism of Prodigiosin from Serratia marcescens Subsp. lawsoniana in Human Choriocarcinoma and Prostate Cancer Cell Lines

5. The prodigiosins, proapoptotic drugs with anticancer properties

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Amino Acid Supplementation on Prodigiosin and its Derivatives Production Using Agro-Waste as Potential Substrate;Indian Journal of Microbiology;2024-07-31

2. Prodigiosin: unveiling the crimson wonder – a comprehensive journey from diverse bioactivity to synthesis and yield enhancement;Frontiers in Microbiology;2024-06-05

3. Decylprodigiosin: a new member of the prodigiosin family isolated from a seaweed-associated Streptomyces;Frontiers in Pharmacology;2024-03-21

4. Isolation, Identification, and Antibacterial Properties of Prodigiosin, a Bioactive Product Produced by a New Serratia marcescens JSSCPM1 Strain: Exploring the Biosynthetic Gene Clusters of Serratia Species for Biological Applications;Antibiotics;2023-09-20

5. A metabologenomics approach to unlock the metabolome of the novel Antarctic deep-sea isolate Lacinutrix shetlandiensis sp. nov. WUR7;PNAS Nexus;2023-07